Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an α-particle-emitting immunoconjugate

This publication has 32 references indexed in Scilit:

• Chimeric anti-tenascin antibody 81C6: Increased tumor localization compared with its murine parent
  Nuclear Medicine and Biology, 1996
• Specific absorbed fractions of energy from internal photon sources in brain tumor and cerebrospinal fluid
  Medical Physics, 1995
• Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary report
  Journal of Neuro-Oncology, 1995
• Quantitation of 211At in small volumes for evaluation of targeted radiotherapy in animal models
  Nuclear Medicine and Biology, 1995
• Preparation and quality control of ²¹¹At‐labelled and ¹²⁵I‐labelled monoclonal antibodies. Biodistribution in mice carrying human osteosarcoma xenografts
  Journal of Labelled Compounds and Radiopharmaceuticals, 1994
• Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin
  Journal of Neuroimmunology, 1994
• Preparation and evaluation of para-[211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab′)2. In vivo distribution comparison with para-[125I]iodobenzoyl labeled A6H F(ab′)2
  Nuclear Medicine and Biology, 1993
• G2M arrest and apoptosis in murine T lymphoma cells following exposure to 212Bi alpha particle irradiation
  Nuclear Medicine and Biology, 1993
• The in Vitro Radiobiology of Astatine-211 Decay
  Radiation Research, 1986
• Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain?
  Neuropharmacology, 1973